Alka-seltzer Cool Action Extra Strength Reliefchews Mintcalcium carbonate

According to the FDA label: Uses relieves acid indigestion heartburn sour stomach upset stomach associated with these symptoms

45,827 adverse event reports submitted to the FDA (2002–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Alka-seltzer Cool Action Extra Strength Reliefchews Mint in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Alka-seltzer Cool Action Extra Strength Reliefchews Mint adverse event reports by reporter sex
SexReports
Female28,688
Male13,573
Unknown45

By Age Group

View age group data as a table
Alka-seltzer Cool Action Extra Strength Reliefchews Mint adverse event reports by reporter age group
Age groupReports
0-171,258
18-341,701
35-494,751
50-648,332
65-747,811
75+7,545

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Alka-seltzer Cool Action Extra Strength Reliefchews Mint. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Alka-seltzer Cool Action Extra Strength Reliefchews Mint adverse event reports by reported outcome
OutcomeReports
Other Serious25,588
Hospitalization21,937
Non-Serious7,353
Death6,916
Life-Threatening5,339
Disability3,905

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Alka-seltzer Cool Action Extra Strength Reliefchews Mint. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Alka-seltzer Cool Action Extra Strength Reliefchews Mint adverse event reports by year
YearReports
20021
20032
2004486
2005489
2006408
2007468
2008464
2009556
20101,209
20113,196
20123,139
2013973
20141,098
20151,768
20162,116
20172,172
20182,471
20192,990
20203,188
20213,341
20223,596
20233,344
20243,933
20253,740
2026 (partial)679

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Alka-seltzer Cool Action Extra Strength Reliefchews Mint

In FDA adverse event reports that mention Alka-seltzer Cool Action Extra Strength Reliefchews Mint, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026